Krka has launched Otomicol ear drops and cutaneous suspension for the treatment of otitis externa and primary and secondary infections of the skin and adnexa1.

Otomicol contains miconazole nitrate, prednisolone acetate and polymyxin B.

The product targets a range of pathogens including miconazole and polymyxin B-sensitive, Malassezia and Pseudomonas spp.

Renzo Di Florio, technical vet at Krka UK, said: “With its multifactorial aetiology, ear disease is often challenging to manage, causing frustration for owners and significant discomfort for pets.

"Otomicol is a cost-effective solution that veterinary surgeons can add to their treatment toolbox for cases where bacterial and fungal infection are important factors.”

Otomicol ear drops and cutaneous suspension are available in a 15ml bottle with an extended shelf life of six months after opening.

Otomicol is available from veterinary wholesalers.

https://www.krka.co.uk 

Reference

  1. https://www.vmd.defra.gov.uk/ProductInformationDatabase/files/SPC_Documents/SPC_2803678.PDF 

PS: Whilst you're here, take a moment to see our latest job opportunities for vet nurses.